Armune Investors
- Intellectual Property -
Armune's intellectual property position for autoantibody technologies includes an exclusive license from the University of Michigan to US, PCT, and WO patents and patent applications, and two patents have been issued, US7,597,890 and US7,858,323. In addition, Armune is augmenting its IP and has filed two new applications based on internal discoveries, PCT/US2011/028845 and PCT/US2011/030091.